*Screening of healthy population not included.

IMPACT OF DIABETES

HEALTH SYSTEM & ECONOMIC SAVINGS

25.8 million Americans

$245billion a year

AFFECTS=

COSTS=

annual savings /person affected$5,886 $34.9M

increased tax revenue

Use of insulin pumps for treatment of people with diabetes generates net cost savings, providing better disease management.

$ thousands

2005 2006 2007 2008 2009 201010

15

20

25

30

35

40

45

22.3

27.5 29.0

35.6

27.7

39.0

24.9

30.6

22.8

29.4

24.9

30.4

Insulin pump Insulin, no pump

* Includes treatment expenditures and indirect impacts.

AVERAGE ANNUAL ECONOMIC BURDEN2008-2010 ($)

Insulin pump $24,217.5

Insulin, no pump $30,103.2

Average savings $5,885.8

1. American Diabetes Association. Economic Cost of Diabetes in the US in 2012. [published online ahead of print March 6, 2013] Diabetes Care. DOI:10.2337/dc12-26255.

GAINLOSS

$101.1billion

$225.4billion

0

5

10

15

20

25

30

35

40

45

$ billions

0.002.74

7.85

15.76

26.97

42.13

2010 2015 2020 2025 2030 2035-25.0

-20.0

-15.0

-10.0

-5.0

0.0

$ billions

-23.52

-12.65

-6.35

-2.79-0.84

0.00

2010 2015 2020 2025 2030 2035

THE FUTURE

ECONOMIC IMPACT OF INSULIN DEPENDENT DIABETES, 2005-2010*Per Person Affected

HEALTHY SAVINGS: MEDICAL TECHNOLOGY & THE ECONOMIC BURDEN OF DISEASE

Increased incentives for medical technology investment used to treat diabetes will generate even larger net savings over time.

Reduced incentives for medical technology used to treat diabetes will result in larger net costs.

Study by Milken Institute. Authors: Anusuya Chatterjee, Jaque King, Sindhu Kubendran, and Ross DeVol. To view the full study, visit: http://lifechanginginnovation.org/get-facts